Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05564273
Other study ID # V211.2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 13, 2023
Est. completion date December 2024

Study information

Verified date December 2023
Source Viome
Contact Mory Mehrtash
Phone (425) 300-6933
Email studies@viome.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.


Description:

Participants who meet the eligibility criteria are randomized into any of the three arms including: the placebo arm, VIOME's condition-based supplements (VCS) arm or the VIOME Precision Nutrition Program (VPNP) arm. Placebo, Viome-designed condition-based supplements and Viome's Precision Nutrition Program include supplements and/or dietary recommendations towards improving the symptoms associated with metabolic wellness. The trial will last approximately 4 months for each participant.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria: - Resident of the United States - Females and males ages 25-75 (inclusive) - Able to speak and read English - No unexplained weight loss, fevers, anemia, or blood in stool - Willing and able to follow the trial instructions, as described in the recruitment letter - Signed and dated informed consent prior to any trial-specific procedures. - Fasting insulin level >=15 uIU/mL or fasting glucose >= 100 mg/dL within the last 3 months, verified from medical records Exclusion Criteria: - Unwilling to change current diet - Unwilling to go to Quest - Prior use of Viome products or services - Antibiotic use in the previous 4 weeks - Women who are pregnant (current or planned in the next 4 months), or breastfeeding - < 90 days postpartum - Active infection - Unable or unwilling to use Viome's App on an iPhone or Android smartphone - Significant diet or lifestyle changes in the previous 1 month - IBD diagnosis - Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial - Cancer therapy within the previous 1 year - Major surgery in the last 6 months or planned in the next 4 months - Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.) - Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.) - Prescribed any drug(s) that may interact with the supplement formulations - Have any medical condition or allergy that may interact with, or prevents the healthy consumption of the supplements such as: Pregnancy Breastfeeding Minors GERD Gastric Ulcers Ulcerative Colitis Crohn's Disease Kidney Impairment (kidney cysts, kidney disease) Liver Condition (gallstones, cholecystitis, cirrhosis, hepatitis, hepatitis a, hepatitis b, hepatitis c, NAFLD/NASH, etc) HIV SIBO CuminAllergy GymnemaAllergy BacopaAllergy CitrusAIlergy LamiaceaeAllergy SageAllergy YeastAllergy MulberryAllergy ChicoryAllergy - Allergies to any study-specific supplement ingredients - Currently on a specific diet: FODMAP KETO PALEO - Gastrointestinal disease including: - GI surgery except: - Appendectomy and benign polypectomy - Esophagitis - Celiac disease - GI malignancy or obstruction - Peptic Ulcer Disease - Duodenal or gastric ulcer disease

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
VIOME Precision Nutrition Program
Precision supplement based on the participants microbiome sample results. Participants in this arm may receive supplements, diet recommendations, and app coaching.
Dietary Supplement:
VIOME-designed condition-based supplements
Pre-formulated supplements based on overall health conditions. Participants in this arm may receive supplements, diet recommendations, and app coaching.

Locations

Country Name City State
United States Viome Life Sciences Bothell Washington

Sponsors (1)

Lead Sponsor Collaborator
Viome

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of VIOME's designed condition based supplements (VCS) Number of participants that show an improvement in metabolic health compared to baseline survey assessment. ~4months
Primary Efficacy of VIOME Precision Nutrition Program (VPNP) Number of participants that show an improvement in metabolic health compared to baseline survey assessment. ~4 months
See also
  Status Clinical Trial Phase
Completed NCT04389736 - Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion N/A
Completed NCT01767051 - Children Follow-up of PCOS Women N/A
Recruiting NCT03670524 - Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project N/A
Completed NCT03082131 - Resistant Starch Wheat for Improved Metabolic Health N/A
Completed NCT03842514 - Food Additives - Do Processed Diets Impact on Gut and Metabolic Health N/A
Recruiting NCT05308381 - Breakfast, Exercise and Metabolic Health in Healthy Women N/A
Recruiting NCT05291065 - Breakfast, Exercise and Metabolic Health in Healthy Men N/A
Completed NCT03969745 - Effects of Two-weeks of Time Restricted Feeding on Basal and Postprandial Metabolism in Healthy Men N/A
Recruiting NCT05820490 - ImpaCt Of Shiftwork on METabolic Flexibility and Skeletal Muscle Clocks
Completed NCT02585336 - Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly N/A
Withdrawn NCT06354101 - The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
Not yet recruiting NCT05912699 - A Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes N/A
Not yet recruiting NCT05917314 - A Study to Evaluate the Effect of SlimBiotics Probiotic Formula on Weight Management and Metabolic Health Outcomes N/A
Recruiting NCT05774574 - Physiological and Appetitive Effects of CBD Supplementation N/A
Completed NCT05306613 - Breaking Sitting and Metabolic Health in Sedentary Lean Adults N/A
Completed NCT05306678 - Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults N/A
Completed NCT05911490 - Effects of Breaking Sitting on Human Behaviour and Metabolic Health N/A